Evidence map›Paper›PMID 40385897›Full record

ArticleCureus2025

A Case of Rosai-Dorfman Disease Complicated by Bone Metastasis From Prostate Cancer.

Qiongying Chen, Yueqiao Zhao, Ke Zhou

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Qiongying ChenRadiology Department, Zigong Third People's Hospital, Zigong, CHN.
Yueqiao ZhaoRadiology Department, Zigong Third People's Hospital, Zigong, CHN.
Ke ZhouRadiology Department, Zigong Third People's Hospital, Zigong, CHN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rosai-Dorfman disease (RDD) is a rare myeloproliferative disorder of histiocytes. The cause of the disease remains unclear. RDD mainly affects lymph nodes and has many extranodal manifestations, including the skin, lungs, eyes, and gastrointestinal tract. This report details a diagnostically challenging case where retroperitoneal lymphadenopathy initially suspected as metastatic prostate adenocarcinoma was pathologically confirmed as RDD. The concurrent occurrence of these two distinct pathologies underscores the importance of histopathological verification in atypical presentations, particularly for guiding precision oncology management.

Indexed as

bone metastasesmyeloproliferative disorderpalliative careprostate cancerrosai–dorfman disease

Identifiers

PMID40385897
PMCPMC12085250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.